IP Library Patent Application 11837651
Patent Application
App. No. 11/837,651

METHOD AND DEVICE FOR DETECTING THE PRESENCE OF A SINGLE TARGET NUCLEIC ACID IN A SAMPLE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/837,651
Abstract

A method comprising depositing a sample portion in a sample retaining means, and forcing a curable fluid across an exposed surface of the sample retaining means, thereby displacing excess first sample from the exposed surface without displacing the sample from the sample retaining means. Also, a method comprising depositing a sample portion in a sample retaining means, removing excess sample from an exposed surface of the sample retaining means, and depositing a curable fluid on the exposed surface. Also, a microfluidic device comprising a sample chamber, a first sample portion in the sample chamber, and a curable fluid and/or a cured fluid positioned on an exposed surface of a sample retaining means.

Claims (35)

1 . A method for detecting whether at least one molecule of a target nucleic acid is present in a first sample portion, said method comprising:

depositing at least a first sample portion in a sample retaining means, said first sample portion comprising at least a portion of a first sample;

forcing a curable fluid across an exposed surface of said sample retaining means, thereby displacing any excess first sample from said exposed surface without displacing said sample from said sample retaining means.

2 . A method as recited in claim 1 , wherein as said curable fluid is forced across said exposed surface, a layer of said curable fluid is deposited on said exposed surface and coats a top of said first sample portion.

3 . A method as recited in claim 2 , wherein said method further comprises curing said curable fluid to form a seal for the first sample portion retained in said sample retaining means, whereby said first sample portion is isolated from other sample portions and from excess first sample.

4 . A method as recited in claim 2 , wherein said curable fluid is immiscible with said first sample

5 . A method as recited in claim 1 , wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first sample chamber after a single round of amplification.

6 . A method as recited in claim 5 , wherein said method further comprises:

subjecting said first sample portion in said first sample chamber to at least a first amplification step; and then

determining whether said first sample portion contains at least one molecule of said target nucleic acid.

7 . A method for detecting whether at least one molecule of a target nucleic acid is present in a first sample portion, said method comprising:

depositing at least a first sample portion in a sample retaining means, said first sample portion comprising at least a portion of a first sample;

removing excess first sample from said exposed surface; and

depositing at least a first curable fluid on said exposed surface of said sample retaining means.

8 . A method as recited in claim 7 , wherein said method further comprises curing said curable fluid to form a seal for the first sample portion retained in said sample retaining means, whereby said first sample portion is isolated from other sample portions and from excess first sample.

9 . A method as recited in claim 8 , wherein said curing said curable fluid is conducted immediately after said removing excess first sample from said exposed surface.

10 . A method as recited in claim 7 , wherein said curable fluid is immiscible with said first sample

11 . A method as recited in claim 7 , wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first sample chamber after a single round of amplification.

12 . A method as recited in claim 11 , wherein said method further comprises:

subjecting said first sample portion in said first sample chamber to at least a first amplification step; and then

determining whether said first sample portion contains at least one molecule of said target nucleic acid.

13 . A microfluidic device comprising:

a first sample chamber; and

a first sample portion, said first sample portion being positioned in said first sample chamber; and

a curable fluid positioned on an exposed surface of said sample retaining means, said curable fluid covering at least said first sample portion.

14 . A microfluidic device as recited in claim 13 , wherein said curable fluid is immiscible with said first sample

15 . A microfluidic device as recited in claim 13 , wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first sample chamber after a single round of amplification.

16 . A microfluidic device as recited in claim 13 , wherein said microfluidic device further comprises at least one amplification targeting reagent positioned in said first sample portion.

17 . A microfluidic device comprising:

a first sample chamber; and

a first sample portion, said first sample portion being positioned in said first sample chamber; and

a cured fluid positioned on an exposed surface of said sample retaining means, said cured fluid covering at least said first sample portion.

18 . A microfluidic device as recited in claim 17 , wherein said cured fluid forms a seal for the first sample portion retained in said sample retaining means, whereby said first sample portion is isolated from other sample portions and from excess first sample.

19 . A microfluidic device as recited in claim 17 , wherein if said first sample portion contains at least a single molecule of said target nucleic acid, said first sample portion would attain a detectable concentration of said target nucleic acid within a portion of said first sample chamber after a single round of amplification.

20 . A microfluidic device as recited in claim 17 , wherein said microfluidic device further comprises at least one amplification targeting reagent positioned in said first sample portion.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE PROPERTY NOS.; CONVEYING PARTY INTEREST; CONVEYING PARTY NAME/ADDRESS PER MERGER RECORDED 6/9/2010, REEL 024508, FRAME 0142. PREVIOUSLY RECORDED ON REEL 023950 FRAME 0123. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 22, 2010
From: GENOMIC NANOSYSTEMS CORPORATION
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 024563/0930 →
MERGER Recorded Jun 9, 2010
From: GENOMIC NANOSYSTEMS, LLC
To: GENOMIC NANOSYSTEMS CORPORATION
Reel/Frame 024508/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2010
From: GENOMIC NANOSYSTEMS, LLC
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023950/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2009
From: CYTONIX CORPORATION
To: GENOMIC NANOSYSTEMS, LLC
Reel/Frame 022427/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: BROWN, JAMES F.
To: CYTONIX CORPORATION
Reel/Frame 022421/0098 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2009
From: SILVER, JONATHAN E.
To: THE UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 022421/0115 →